Tom Lilly Stephen
Login to view DISC.Tom Lilly Stephen is an immuno-oncologist with 20 years of research experience in anti-tumor immunity and drug resistance. As a founder of multiple biotech companies, including Jeevan Therapeutics and a stealth-mode venture, he focuses on developing innovative drugs for unmet patient needs. He holds a PhD from the University of Cologne.
He is deeply engaged in the biotech ecosystem, actively attending events like the Boston Biotech Investor Day and following industry trends. Tom shows a keen interest in the journey of startups, from building and funding to scaling, and closely follows strategic collaborations within the biopharmaceutical space.
He has co-authored research on how the SATB1 protein governs the epigenetic repression of PD-1 in T cells, a key pathway in cancer immunity.
Read the full overview →How Tom shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Tom cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.